Ron is Addition’s Chief Executive Officer, where he leads the company’s strategic vision and key stakeholder relationships. He brings decades of leadership experience across the life sciences sector. Prior to joining Addition, Ron served as CEO of Ambys Medicines, and previously held senior executive roles at Genentech, Roche, and Ancestry.  Earlier in his career, he worked at McKinsey and UCLA.  Ron holds an MD and MBA from Stanford University and a BA in Biology from Harvard University. He is passionate about building and leading companies that translate cutting-edge innovation into transformative advances for human health.